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Abstract
Chlamydia trachomatis is an obligate intracellular bacterium that alternates between two metabolically different
developmental forms. We performed fluorescence lifetime imaging (FLIM) of the metabolic coenzymes, reduced
nicotinamide adenine dinucleotides [NAD(P)H], by two-photon microscopy for separate analysis of host and pathogen
metabolism during intracellular chlamydial infections. NAD(P)H autofluorescence was detected inside the chlamydial
inclusion and showed enhanced signal intensity on the inclusion membrane as demonstrated by the co-localization with
the 14-3-3b host cell protein. An increase of the fluorescence lifetime of protein-bound NAD(P)H [t2-NAD(P)H] inside the
chlamydial inclusion strongly correlated with enhanced metabolic activity of chlamydial reticulate bodies during the mid-
phase of infection. Inhibition of host cell metabolism that resulted in aberrant intracellular chlamydial inclusion morphology
completely abrogated the t2-NAD(P)H increase inside the chlamydial inclusion. t2-NAD(P)H also decreased inside chlamydial
inclusions when the cells were treated with IFNc reflecting the reduced metabolism of persistent chlamydiae. Furthermore,
a significant increase in t2-NAD(P)H and a decrease in the relative amount of free NAD(P)H inside the host cell nucleus
indicated cellular starvation during intracellular chlamydial infection. Using FLIM analysis by two-photon microscopy we
could visualize for the first time metabolic pathogen-host interactions during intracellular Chlamydia trachomatis infections
with high spatial and temporal resolution in living cells. Our findings suggest that intracellular chlamydial metabolism is
directly linked to cellular NAD(P)H signaling pathways that are involved in host cell survival and longevity.
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Introduction
The obligate intracellular bacterium Chlamydia trachomatis (C.
trachomatis) has two metabolically different developmental forms,
which ensure its infectivity and replication. The infectious form,
the elementary body, enters the host cell and differentiates into a
metabolically active form, the reticulate body. Chlamydial
reticulate bodies grow within the host cell in an intracellular
membrane-bound compartment called the chlamydial inclusion.
Within 24 hours post infection (hpi), numbers and size of reticulate
bodies are maximized and chlamydiae start to re-differentiate to
infectious elementary bodies. Cell lysis and release of the
elementary bodies occur at around 48 hpi [1].
C. trachomatis is a sensitive marker organism for host cell
metabolic changes because it strongly depends on ATP and
metabolites generated by the host. Although an ADP/ATP
transporter has been found [2,3], the genome sequence also
unraveled the existence of several glucose metabolizing enzymes
[4]. Since then, it has been speculated that C. trachomatis not only
uses host cell ATP, but also is capable to produce its own energy
[5]. However, the metabolic pathways of C. trachomatis are often
truncated. Thus, C. trachomatis might directly import the substrates
required to compensate for the incomplete metabolic pathways
[4]. Using microarray technology, it was shown that the ADP/
ATP translocase and the ATP requiring oligopeptide transporters
are expressed as immediate early genes. Furthermore, some
metabolic enzymes such as the malate dehydrogenase (which
requires nicotinamide-adenine dinucleotide (NAD) as cofactor) are
also expressed in the early phase of infection [6]. Interestingly, no
pathways for the biosynthesis of NAD and no NAD kinase for the
synthesis of phosphorylated NAD have been found in the
chlamydial genome. Although it seems obvious that a system to
import NAD(P) from the host cell must exist similarly to that of
environmental chlamydiae, no NAD(P) transporter has yet been
identified in C. trachomatis according to sequence homology
searches [7]. It is therefore reasonable to assume that intracellular
chlamydial development strongly depends on host cell NAD
availability.
The lack of suitable methods to investigate chlamydial
metabolism separately from host cell metabolism has hindered
scientific progress in studying host and pathogen metabolic
interactions. Current knowledge on chlamydial metabolism is
restricted to micro-array and RT-PCR analyses about the
expression of metabolic genes during different intracellular
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mydial metabolic enzymes, and the biochemical analysis of
infected cells [1,5,6,8–10]. Recently, it was shown by Raman
microspectroscopy that amino acid uptake and protein synthesis is
preserved in C. trachomatis after extracellular incubation [11].
Increases in glucose consumption and ATP levels were observed in
cells infected with chlamydiae, however these studies could not
distinguish between host cell and bacterial metabolism [12,13].
Fluorescence lifetime imaging (FLIM) of NAD(P)H using two-
photon laser scanning microscopy has been used to study cellular
metabolism in living cells by utilizing the autofluorescence
properties of the reduced form of the metabolic cofactor, NAD
[NAD(H)] and its phosphorylated form, NADP [NAD(P)H] [14–
17]. At 730–750 nm excitation, the cellular autofluorescence as
measured by two-photon microscopy is dominated by NAD(P)H
[14,16,18,19]. The fluorescence lifetime is the time that a molecule
spends to return to its ground state from its excited state. This
exponential decay rate can be measured by time correlated single
photon counting (TCSPC). The fluorescence lifetime of a molecule
is thereby independent of its total concentration but strongly
depends on its respective protein binding within a given
microenvironment [20]. Thus, NAD(P)H functions are deter-
mined by binding to different cellular proteins. NAD(H) is a
cofactor for catabolic reactions in the cytosol and the mitochon-
dria while the phosphorylated NADP(H) is a cofactor in anabolic
reactions and plays an important role in the cellular anti-oxidative
defense system [21,22]. NADH is generated within the glycolytic
pathway by glyceraldehyde-phosphate-dehydrogenase (GAPDH)
in the host cell cytosol while NADPH is produced by the enzymes
of the pentose-phosphate pathway. In the mitochondria,
NAD(P)H cannot pass through the inner mitochondrial mem-
brane and only electrons from NAD(P)H are carried across by the
malate-aspartate shuttle for oxidative phosphorylation. By con-
trast, free NAD(P)H can cross the nuclear envelope by diffusion
through the nuclear pores; therefore, changes of cytosolic levels of
free NAD(P)H are represented in the nucleus. An important
binding protein of NADH in the nucleus is the transcriptional co-
repressor, C-terminal binding protein (CTBP) [23]. Consequent-
ly, nuclear NADH functions to control gene transcription by
regulating CTBP. [24]. Importantly, fluorescence lifetimes of
NAD(P)H significantly differ between cytosol, mitochondria and
nucleus in one single cell [19]. Differences of the NAD(P)H
fluorescence lifetimes that are based on the different protein-
bindings of NAD(P)H reflect the diverse physiological functions in
these cellular compartments. Thus, monitoring of NAD(P)H
fluorescence lifetimes allow for a compartmentalized analysis of
cellular metabolic changes over time. In addition, calculating the
bi-exponential fluorescence decay enables not only the monitor-
ing of different components of the fluorescence lifetimes but also
the ratio of free to protein-bound NAD(P)H [14,15]. The
fluorescence lifetime of protein-bound NAD(P)H [t2-NAD(P)H]
is longer than that of free NAD(P)H [t1-NAD(P)H] [20]. As free
NAD(P)H is readily diffusible, regulation of its binding proteins is
correlated to the relative amount of free NAD(P)H [24]. The
value of t2-NAD(P)H and the ratio of free to protein-bound
NAD(P)H are established markers to sensor metabolic activity of
eukaryotic cells and have been used to monitor changes in host
cell glycolysis or oxidative phosphorylation [15,19,25]. Inhibition
of glycolysis results in an increase of t2-NAD(P)H while the
inhibition of oxidative phosphorylation decreases t2-NAD(P)H.
The shift from oxidative phosphorylation to glycolysis has been
made responsible for the decrease of t2-NAD(P)H during cancer
development [15]. Furthermore, FLIM is the only currently
available method to determine compartmentalized redox state of
NAD(P)H in living cells.
We applied two-photon FLIM of NAD(P)H to discriminate and
thoroughly characterize chlamydial and host cell metabolism. By
measuring t2-NAD(P)H values and determining the ratio of free to
protein-bound NAD(P)H in C.trachomatis-infected cells, we ob-
served significant changes both in host cell and chlamydial
metabolism during the intracellular developmental cycle.
Results
Compartmentalization of NAD(P)H in C. trachomatis-
infected cells
In non-infected HEp-2 cells, the majority of cellular autofluo-
rescence at 730 nm excitation originated from the mitochondria.
The cytosol and nuclei showed reduced fluorescence, representing
the compartmentalized distribution of NAD(P)H in the cells
(Figure 1A). To confirm that NAD(P)H is the major contributor to
cellular autofluorescence at 730 nm excitation, the autofluores-
cence spectra were measured in four different emission channels.
The highest emission intensity of autofluorescence was between
380 nm and 500 nm in all cellular compartments, corresponding
to the peak of NAD(P)H fluorescence emission (Figures S1A and
S1B). In C. trachomatis-infected cells a new compartment is formed,
the chlamydial inclusion which also showed a strong autofluores-
cence signal (Figure 1A). The spectra of the chlamydial
fluorescence did not show any shift compared to the autofluores-
cence of the other cellular compartments, indicating that the
fluorescence inside the chlamydial inclusion also originated
primarily from NAD(P)H (Figures S1A and S1B). The chlamydial
inclusions could be clearly distinguished from the host cells due to
the different fluorescence intensity of NAD(P)H inside the
chlamydial inclusion (Figures S2A and S2B). The selected region
of interest (ROI) was then used to determine fluorescence lifetimes
of NAD(P)H inside the chlamydial inclusion and other cellular
compartments. We observed a broad distribution of t2-NAD(P)H
Author Summary
Separate analysis of host and pathogen metabolic changes
in intracellular C. trachomatis infections is arduous and has
not been comprehensively realized so far. A more detailed
understanding about the metabolic activity and needs of
C. trachomatis and its specific interactions with the host
cell would be the basis for the development of novel
treatment strategies. We therefore applied fluorescence
lifetime imaging (FLIM) of the metabolic coenzymes
NAD(P)H using two-photon microscopy to directly visual-
ize metabolic changes of host cells and pathogens in living
cells. NAD(P)H fluorescence was detected both on the
chlamydial inclusion membrane and inside the inclusion.
Interestingly, changes in chlamydial growth and progeny
induced by glucose starvation and IFNc treatment were
directly linked to significant changes of the NAD(P)H
fluorescence lifetimes inside the inclusions. Furthermore,
measurement of the NAD(P)H fluorescence lifetime in the
host cell nucleus revealed that infected cells were
programmed for starvation during the metabolically active
phase of intracellular chlamydial growth. Our findings
highlight for the first time a direct interaction between
host and pathogen metabolism in intracellular bacterial
infections that exceeds sole competition for nutrients. In
conclusion, fluorescence lifetime imaging of NAD(P)H by
two-photon microscopy enables real-time analysis of
metabolic host-pathogen interactions in intracellular
infections with high spatial and temporal resolution.
Imaging of Host-Pathogen Metabolism
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cellular compartment (Figure S2C). We could confirm that the
mean values of t2-NAD(P)H in the cytosol, nucleus, mitochondria
and chlamydial inclusion were significantly different (overall
significance p,0.0001). The mean lifetime values are listed in
Table S1. In addition, t2-NAD(P)H was significantly increased
inside the chlamydial inclusion at 24 hpi compared to all the other
cellular compartments (Figure 1B).
Non-mitochondrial NAD(P)H fluorescence surrounding
the chlamydial inclusion
NAD(P)H fluorescence showed an increased intensity surround-
ing the chlamydial inclusion. To test whether the high intensity
signal originated from the host cell mitochondria, we co-incubated
the cells with a mitochondria marker, tetramethylrhodamine-
ethyl-ester (TMRE). TMRE showed complete co-localization with
the high intensity NAD(P)H fluorescence in non-infected HEp-2
cells (Figures 2A and S3A). By contrast, in C. trachomatis-infected
cells, high intensity signals only partially co-localized with TMRE.
Most of the high intensity fluorescence which was found around
the chlamydial inclusion did not co-localize with host cell
mitochondria that were labeled with TMRE (Figures 2A and
S3B). This high intensity signal around the inclusion also did not
show co-localization with the GFP-tagged lysosomal and golgi
markers that were overexpressed in C. trachomatis-infected cells
(Figure 2B). Overexpression of the GFP-tagged 14-3-3b protein
that was previously shown to be localized on the inclusion
membrane [26] co-localized with NAD(P)H indicating that the
high intensity NAD(P)H fluorescence derives from the inclusion
membrane in C. trachomatis-infected cells (Figure 2C).
Fluorescence lifetime changes of NAD(P)H in the
chlamydial inclusions during the developmental cycle
To verify our hypothesis that changes in the values of t2-
NAD(P)H inside the chlamydial inclusion are an indicator of
chlamydial metabolism, we followed the alterations of t2-
NAD(P)H during the developmental cycle of C. trachomatis
(Figure 3A). Increased metabolism of reticulate bodies during the
mid-phase of intracellular growth was directly correlated with an
increase of t2-NAD(P)H between 12 and 4 hpi. By contrast, t2-
NAD(P)H did not change further during the late phase of the
infection (48 hpi) when infectious elementary bodies were formed
(Figure 3B). However, the distribution of t2-NAD(P)H was more
heterogeneous at 48 hpi (Figure S4A) whereas the ratio of free to
protein-bound NAD(P)H (a1/a2 ratio) inside the chlamydial
inclusion significantly decreased between 12 and 24 hpi (Figure
S4B).The distribution and intensity of fluorescence in the
chlamydial inclusions also changed during the developmental
cycle. While highest fluorescence in the mid-phase of the
chlamydial development was observed at the inner border of the
inclusion, the average fluorescence intensity increased and was
homogeneously distributed within the inclusion within 24 hpi.
During late infection, large areas inside the inclusion showed no
NAD(P)H fluorescence, indicating replacement of metabolically
active reticulate bodies by infectious but metabolically inert
elementary bodies (Figures S5A, S5B and S5C). An increase of
t2-NAD(P)H was also observed in inclusions from early C.
pneumoniae infected cells, followed by a decline in t2-NAD(P)H
during later time points of the infection (Figures S6A and S6B).
Inhibition of host cell metabolism directly interferes with
the development and metabolism of C. trachomatis
To further prove that t2-NAD(P)H characterizes the metabolic
activity of C. trachomatis, we monitored t2-NAD(P)H changes inside
the chlamydial inclusion during inhibition of host cell metabolism.
We used glucose starvation to inhibit host cell glycolysis and
antimycin A to inhibit the mitochondrial complex III and
subsequent oxidative phosphorylation. Both inhibitors decreased
host cell ATP levels (Figure S7A). The intracellular development
of C. trachomatis was monitored by immunofluorescence staining
and electron microscopic (EM) imaging of chlamydial inclusions
(Figure 4A). Sizes of chlamydial inclusions were quantitatively
analyzed at 24 hpi and the numbers of infectious C. trachomatis
progeny were measured by recovery assays (Figures 4B and 4C).
Both glucose starvation and treatment with antimycin A resulted
in smaller and aberrant chlamydial inclusions when compared to
untreated cells. Quantification of the fluorescence lifetimes showed
a significant decrease of t2-NAD(P)H inside the C. trachomatis
inclusions when the host cells were treated with the metabolic
inhibitors, as an indicator for decreased metabolism of C.
trachomatis (Figures 4D and S7B). The observed decrease in the
t2-NAD(P)H values was directly correlated to the decreased
recovery rate of infectious C. trachomatis.
Decreased t2-NAD(P)H and relative amount of protein-
bound NAD(P)H in persistent chlamydial inclusions
Interferon-c (IFNc) is known to induce C. trachomatis persistence
that is defined as a viable but non-cultivable developmental stage.
Persistent C. trachomatis are characterized by enlarged reticulate
bodies in morphological aberrant inclusions [27]. To determine
the metabolism of reticulate bodies in persistence, we measured
the t2-NAD(P)H values inside the chlamydial inclusions in IFNc-
treated cells 24 hpi. The mean values of t2-NAD(P)H (Figures 5A
and 5C) and the size of the inclusions (Figure 5D) were decreased
in persistent infections. The relative amount of protein-bound a2-
NAD(P)H was also largely reduced resulting in an increase of the
a1/a2 ratio (Figures 5B and 5E).
Decrease in the relative amount of free NAD(P)H in the
host cell nucleus indicates cellular starvation in
C. trachomatis-infected cells
In the late phase of C. trachomatis-infection, FLIM analysis of
cellular NAD(P)H was impeded by the large sizes of the
chlamydial inclusions filling out almost the whole cytosol of the
cells. As free NAD(P)H is diffusible, cytosolic levels are reflected in
the cell nucleus. To characterize host cell metabolism during later
Figure 1. NAD(P)H fluorescence intensity signals and t2-NAD(P)H in non-infected and C.trachomatis-infected cells. (A) FLIM of NAD(P)H
by two-photon microscopy in non-infected (upper panels) and C. trachomatis-infected (lower panels) HEp-2 cells at 24 hpi. Left panels: Greyscale
images of NAD(P)H fluorescence intensity signals. Right panels: Color-coded images of t2-NAD(P)H. White squares show ROIs of cellular
compartments used for quantitative analysis of t2-NAD(P)H (C: cytosol, M: mitochondria, N: nucleus, I: inclusion; scale bar=20 mm). (B) Quantitative
analysis of t2-NAD(P)H in the cytosolic, mitochondrial and nuclear compartments of non-infected cells and in the chlamydial inclusion of infected cells
showed significantly increased t2-NAD(P)H inside the chlamdial inclusions compared to other cellular compartments at 24 hpi. (n=54 ROIs from
three independent experiments, mean6SEM). Detailed results of statistical analysis are shown in Table S2. Images show enlargement of
representative ROIs used for analysis. ROIs were selected by signal intensities. Low intensity areas were selected as cytoplasma and nucleus, high
intensity areas as mitochondria. For the analysis of the inclusions, ROIs were selected inside the inclusion (see Figure S2A and S2B).
doi:10.1371/journal.ppat.1002108.g001
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bound NAD(P)H (a1/a2) and the values of t2-NAD(P)H in the
nucleus. The ratio of a1/a2 was decreased and t2-NAD(P)H was
increased in the nucleus of C. trachomatis-infected cells at 24 hpi
(Figure 6A-C). Similar effects were observed when host cell
glycolysis was inhibited by 2-fluoro-deoxy-glucose (2FDG) or by
glucose deprivation (data not shown) that mimic cellular
starvation. The results indicate decreased levels and altered
protein binding of NAD(P)H in the nucleus as a consequence of
metabolic changes in the host cell cytosol.
Discussion
C. trachomatis was speculated to be an energy parasite that totally
depends on the supply of energy and metabolic co-enzymes from
the nutrient-rich cytoplasm of an infected host cell. In recent years,
when genome data became available and with the use of
functional enzymatic competition assays, it became obvious that
chlamydiae contain the capacity to produce its own energy and
reducing power [5]. However, separate analysis of host and
pathogen metabolism is still challenging and requires novel
experimental and technical set-ups that facilitate dynamic
monitoring of metabolic changes inside the intracellular chlamyd-
ial inclusion separately from the host cell in living cells. Imaging of
NAD(P)H by its autofluorescence is an ideal tool to study
metabolism in C. trachomatis-infected cells as it permits the spatial
separation of metabolic changes in different cellular compartments
[19]. By use of the two-photon microscopy technique lateral
resolutions of below 1 mm are achieved with a maximum
reduction in photo-damage over time. Changes in the NAD(P)H
Figure 2. Non-mitochondrial NAD(P)H fluorescence in C. trachomatis-infected cells. (A) In non-infected HEp-2 cells (left panels), the
mitochondria marker TMRE (middle panels; fluorescence emission between 580–680 nm, depicted in green) co-localizes (lower panels) with the high
intensity NADP(H) fluorescence signal (upper panels; fluorescence emission between 450–500 nm, depicted in red). In C. trachomatis-infected cells
(24 hpi, right panels), the arrows point to high intensity non-mitochondrial NAD(P)H signals of the chlamydial-inclusions. TMRE and NAD(P)H were
excited at 730 nm (scale bar=20 mm). (B) CellLight Lysosomes-GFP (left panel) and CellLight Golgi-GFP (right panel) did not co-localize with NAD(P)H
autofluorescence in C. trachomatis-infected cells at 24 hpi. GFP was excited at 840 nm and NAD(P)H was excited at 730 nm. Pictures are overlays of
pseudocolor images (GFP=green, NAD(P)H=red; scale bar=10 mm). (C) Overexpressed 14-3-3b-GFP protein co-localized with the NAD(P)H
autofluorescence in C. trachomatis-infected cells at 24 hpi. 14-3-3b-GFP showed increased fluorescence at the chlamydial inclusion membrane (left
panels). Pseudocolor image (right panel) of NAD(P)H fluorescence (excited at 730 nm, red) and GFP fluorescence (excited at 840 nm, green) shows
the overlay. The fluorescence intensity profile (middle panel) of the line indicated in the original and in the magnified picture (lower panel) confirm
the co-localization of 14-3-3b-GFP and NAD(P)H fluorescence at the chlamydial inclusion membrane (scale bar=10 mm).
doi:10.1371/journal.ppat.1002108.g002
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characteristics of NAD(P)H and allow to calculate the relative
amount of free NAD(P)H in ratio to protein-bound NAD(P)H
[14].
First we studied the compartmentalized distribution of
NAD(P)H fluorescence in C. trachomatis-infected cells. This
uncovered a high intensity NAD(P)H fluorescence around the
chlamydial inclusion which was not of mitochondrial origin.
Previous findings that the C. trachomatis-inclusion does not co-
localize with the mitochondria of the host cells were confirmed
[28]. Unlike the nuclear pore, the chlamydial inclusion is passively
impermeable to small molecules rendering sole diffusion of
NAD(P)H across the inclusion membrane unlikely [29]. The co-
localization of the non-mitochondrial NAD(P)H signal with the
inclusion marker 14-3-3b host cell protein indicates that it might
represent a potential NAD(P)H transporter or the active site where
NAD(P)H is synthesized for chlamydial use. The existence of
NAD(P) transporter in environmental chlamydiae [7] suggests that
human pathogenic chlamydiae also harbour a transporter rather
than a biosynthetic pathway because of its smaller genome size.
Our data on the distribution of NAD(P)H fluorescence within
the chlamydial inclusion further supports the model from Wilson
et al. that reticulate bodies first occupy the juxta-membrane space
during the formation of the chlamydial inclusion and later move to
the centre for differentiation [30]. In the centre of the inclusion,
limited supply of essential metabolites may ultimately trigger their
re-differentiation to infectious elementary bodies [31].
The significantly increased t2-NAD(P)H values inside the
chlamydial inclusion define a novel, metabolically distinct cellular
compartment within infected cells. Comparison of the classical
NAD(P) binding domains in humans and C. trachomatis using the
SUPERFAMILY database search (http://supfam.cs.bris.ac.uk/
SUPERFAMILY_1.73/) [32] indicated that the Rossmann-fold
[33] is present in 318 proteins in humans but only in 14 proteins of
C. trachomatis (L2b/UCH-1/proctitis). Our measurements of t2-
NAD(P)H values during the developmental cycle indicate that
NAD(P)H within C. trachomatis inclusion binds to different proteins
as its metabolism changes. In addition, our results indicate that t2-
NAD(P)H strongly correlates with the metabolic activity of
chlamydial reticulate bodies but not with the inclusion size. The
increase in t2-NAD(P)H in the mid- phase of infection was
accompanied by a decrease in the relative amount of free
NAD(P)H, which might indicate the presence of an oxidative
type of energy metabolism within the chlamydial inclusion [4].
Similar changes of t2-NAD(P)H were measured in C. pneumoniae
inclusions. The longer developmental cycle of the bacteria allowed
also monitoring the decrease in metabolism towards the end of the
infection cycle. However the absolute changes that we could
measure were also less pronounced.
IFNc induces persistence of C. trachomatis [34]. The molecular
mechanism involves tryptophan depletion through the induction
of the indoleamine 2,3-dioxygenase (IDO) by IFNc [35]. By
measuring t2-NADP(H) and the ratio of a1/a2 in the persistent
chlamydial inclusions we could prove that the metabolism of the
chlamydial reticulate bodies are largely reduced. In addition, we
could visualize the enlarged reticulate bodies inside the inclusions.
Reduction of host cell ATP synthesis by inhibition of glycolysis
or oxidative phosphorylation induced aberrant chlamydial inclu-
sions and decreased t2-NAD(P)H values in the chlamydial
inclusions. Therefore, t2-NAD(P)H values predicted metabolic
activity of growing and differentiating reticulate bodies that
resulted in infectious chlamydial progeny.
Looking more in detail on the ratio of free to protein-bound
NAD(P)H in the host cell nucleus, we could also show that
intracellular chlamydial infection programmed the cell for
starvation. Free NAD(P)H, which is approximately 80% of the
total amount of NAD(P)H, represents the freely diffusing
NAD(P)H molecules as described by measuring fluorescence
lifetime of NADH in solution [36]. As there is no barrier for the
diffusion of free NAD(P)H between the cytosolic and nuclear
compartments, nuclear NAD(P)H concentrations directly reflect
the free cytosolic NAD(P)H concentrations [24]. The t2-NAD(P)H
Figure 3. Changes of t2-NAD(P)H inside the chlamydial
inclusions during the intracellular developmental cycle. HEp-2
cells were infected with C. trachomatis, for 12, 18, 24, 36 and 48 hours.
(A) Schematic presentation of bacterial inclusion formation in C.
trachomatis-infected cells (EB=elementary body, RB=reticulate body,
N=nucleus, I=inclusion). Representative color-coded images of t2-
NAD(P)H in C. trachomatis-infected cells at the indicated times of
infection are shown (scale bar=10 mm). White squares show ROIs inside
the chlamydial inclusion used for quantitative analysis of t2-NAD(P)H.
Chlamydial inclusions are marked by dashed lines. (B) Quantitative
analysis of t2-NAD(P)H inside the chlamydial inclusion and of chlamydial
inclusion sizes (n=54 from three independent experiments; mean6
SEM). Detailed results of statistical analysis are shown in Table S3A.
doi:10.1371/journal.ppat.1002108.g003
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with those found in 2FDG treated cells in which cellular glycolytic
flux is inhibited and cellular starvation is induced within 24 hours
[19,24]. It is well accepted that calorie restriction and cellular
starvation go along with the induction of gene expression patterns
that allow energy conservation and directly regulate the lifespan of
cells [37]. The deacetylase sirtuin1 (SIRT1) is a master regulator of
longevity in the host cell nucleus and is directly regulated by its
substrate NAD [38] while its transcription is regulated by the
NADH-binding transcriptional corepressor, carboxy-terminal
binding protein 1 (CTBP) [23,24,39].
A limitation of NADP(H) autofluorescence imaging is that
conversion of NAD(P)H fluorescence intensity values to absolute
concentration values is not straightforward because the different
quantum yields of free and protein-bound NAD(P)H have to be
calculated [40,41]. In addition, the fluorescence decay parame-
ters of the phosphorylated and non-phosphorylated forms of
reduced NAD are the same and are indistinguishable. Although
estimations of cellular concentrations suggest that a substantial
part of the cellular fluorescence originates from NADPH rather
than from NADH [21], we and others have demonstrated
significant NAD(P)H fluorescence lifetime changes by inhibiting
glucose metabolism corresponding to projected changes of
cellular NADH concentration [15,40,42]. We would also expect
that NAD(P) transport or synthesis is initiated very early in the
chlamydial developmental cycle as gene-expression analysis
indicates that metabolic enzymes requiring NAD as cofactor
are expressed as immediate early genes [6]. However, because of
the small size of the intracellular C. trachomatis inclusions in the
first 12 hours of infection, a reliable analysis of the NAD(P)H
fluorescence in the early phase of infection could not be
performed.
A more detailed understanding about the metabolic activity and
needs of C. trachomatis during the intracellular growth phase is
needed to conceive novel therapeutic strategies to target the
pathogen in its intracellular growth phase without affecting the
host. Fluorescence lifetime imaging using two-photon microscopy
bares new insights into the crosstalk between host and pathogen
metabolism and suggests C. trachomatis-induced changes in sub-
cellular NAD(P)H contents to directly interfere with nuclear
NAD(P)H signaling pathways that are involved in cellular survival
and longevity. In the process of understanding on how
intracellular pathogens interfere with host cell metabolism,
metabolic profiling of infected cells by FLIM of NAD(P)H will
be an invaluable tool that complements established large scale
genomic and proteomic approaches.
Figure 4. Impact of host-cell metabolism inhibition on chlamydial development and t2-NAD(P)H inside chlamydial inclusions. HEp-2
cells, infected with C. trachomatis, were left untreated (control) or were grown in media without glucose or were treated with 3 nM antimycin A for
24 hours. (A) Upper panels: Immunofluorescence staining images show chlamydial inclusions in green (chlamydial-LPS antibody) and host cells in red
(Evans-blue). Middle panels: Electron microscopic pictures show morphologically aberrant chlamydial development under glucose starvation and
antimycin A treatment at 24 hpi. Arrows indicate EBs while arrowheads indicate RBs inside the chlamydial inclusions (N=nucleus; scale bar=2 mm).
Lower panels: Color-coded images of t2-NAD(P)H. White squares inside the chlamydial inclusions show representative ROIs used for quantitative
analysis (scale bar=20 mm). (B) Inhibition of host cell metabolism decreases the sizes of chlamydial inclusions. Quantitative analyzes of chlamydial
inclusion sizes at 24 hpi. Average sizes of 54 inclusions from three independent experiments are shown as percentage of control. (C) Inhibition of
host cell metabolism decreases the number of infectious chlamydial progeny. Quantitative analysis of C. trachomatis recovery rates at 24 hpi.
Averages of duplicates from three independent experiments are shown. (D) Inhibition of host cell metabolism decreases t2-NAD(P)H inside the
chlamydial inclusion. Quantitative analysis of t2-NAD(P)H (n=54 ROIs from three independent experiments; mean6SEM) at 24 hpi. Results are shown
as percentage of control. Detailed results of statistical analysis are shown in Table S4.
doi:10.1371/journal.ppat.1002108.g004
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Cell culture and propagation of C. trachomatis and
C. pneumoniae
HEp-2 epithelial cells (ATCC CCL-23) were cultured in
Dulbecco’s modified Eagle’s Medium (DMEM) with glucose
(4.5 g/l) (PAA,), or for glucose starvation studies, in glucose free
DMEM (PAA, Germany) supplemented with 10% heat-inactivat-
ed fetal bovine serum (FBS), 4 mM L-glutamine, 110 mg/l
sodium-pyruvate, 10 mg/ml gentamicin and 30 mM Hepes. For
two-photon microscopy, 5610
5 HEp-2 cells per dish were cultured
in 50 mm culture dishes. For recovery assays, 3610
5 HEp-2 cells
per well were cultured in 6-well culture plates. Cells were allowed
to adhere for 24 hours prior to infection with C. trachomatis or C.
pneumoniae. Cells were grown at 37uC, in 5% CO2 humidified air.
C. trachomatis strain L2 (ATCC VR-902B) and C. pneumoniae
CWL029 strain (ATCC VR-1310) were purified on discontinuous
density gradients. HEp-2 cells were infected with 1 inclusion
forming unit (IFU) C. trachomatis per cell. HEp-2 cells were infected
with 4 IFU C. pneumoniae per cell in the presence of 1 mg/ml
cycloheximide by using centrifugation.
FLIM of NAD(P)H by two-photon microscopy
For two-photon microscopic studies, HEp-2 cells were grown on
cover glass in 50 mm culture dishes and infected with C. trachomatis
or C. pneumoniae as described above. Cover glasses were examined
in a MiniCeM chamber for microscopy (JenLab, Jena, Germany)
fitted to a heated stage, which enabled live cell imaging. The two-
photon microscope (DermaInspect; Jenlab) was equipped with a
Chroma 640DCSPXR dichroic mirror (AHF analysentechnik AG,
Tu ¨bingen, Germany) and a 406/1.3 Plan-Apochromat oil-
immersion objective (Zeiss, Go ¨ttingen, Germany). A tunable
infrared titanium-sapphire femtosecond-laser (710–920 nm tuning
range; MaiTai; Spectra Physics, Darmstadt, Germany) was used as
an excitation source at 730 nm excitation for FLIM of NAD(P)H.
Residual excitation light was blocked from the FLIM detector by a
blue emission filter (BG39, Schott AG, Mainz, Germany). FLIM
data were collected by a time-correlated single-photon counting
(TCSPC) system (PMH-100-0, SPC-830, Becker & Hickl, Berlin,
Germany). Single photon counting was done for 49.7 seconds per
image. Fluorescence lifetimes were analyzed using the SPCImage
software version: 2.9.5.2996 (Becker & Hickl). The average power
for the cell imaging experiments was 12 mW, and the scan area for
each image plane was 1106110 mm
2 corresponding to 2566256
pixels. Photon count rates at the beginning and end of image
acquisition were monitored to ensure that photo-bleaching did not
occur. For the image analysis, the ROI inside the chlamydial
inclusion was selected. The ROIs contained 42 to 1147 pixels
depending on the chlamydial inclusion size. The lifetimes of 565
pixels in the ROI were averaged before. The lifetime decay curves
were fit to a double exponential decay model, in which the fast
decaying component corresponds to free NAD(P)H [t1-NAD(P)H]
and the slow decaying component corresponds to protein-bound
NAD(P)H [t2-NAD(P)H[ [14]. The instrument response function
(IRF) was measured from the second harmonic generation signal
of beta-barium-borate crystal and it was used in the lifetime fit
model. The mean values of t2-NAD(P)H of all pixels inside the
ROIs were calculated. ROIs from three cells per microscopy field
were analyzed from six different microscopy fields per chamber on
three independent measurement days [n=54 (36663)]. To
compare t2-NAD(P)H of different infection times and metabolic
states, values were normalized to the average t2-NAD(P)H 24 hpi
(100%) for each experimental day. For fluorescence intensity
analysis of FLIM pictures, photon counts values of selected ROIs
inside the chlamydial inclusion were exported to Excel from
SPCImage analysis software. Values of each pixel inside the ROIs
from three different cells were used to create a histogram of
fluorescence intensity distribution.
Detection of spectrally distributed autofluorescence and
fluorescent labeling of mitochondria
Fluorescence light was collected in four emission channels
simultaneously using a set of dichroic mirrors and four
photomultiplier tubes (Hamamatsu R1294A and R1295A).
Fluorescence emission was spectrally distributed as follows:
channel 1: 380–450 nm, channel 2: 450–500 nm, channel 3:
500–580 nm, channel 4: 580–680 nm. Residual excitation light
was blocked by a two-photon emission filter (E680SP, Chroma
Technology Corp., Bellows Falls, VT). Fluorescence intensities in
each emission channels were analyzed in medium and in ROIs in
host cell mitochondria and chlamydial inclusion by ImageJ.
Background fluorescence intensity was recorded in a dark
measurement without excitation light and was subtracted from
Figure 5. Effects of IFNc treatment on NAD(P)H inside
chlamydial inclusions. HEp-2 cells were infected with C. trachomatis
for 24 hours and treated with 10 units /ml IFNc 24 hours prior to and
during the infection (right panels) or were left untreated (left panels).
(A) Color-coded images of t2-NAD(P)H (scale bar=20 mm). Arrows point
to persistent chlamydial inclusions harbouring enlarged reticulate
bodies. (B) Color-coded images of the relative amount of protein-
bound a2-NAD(P)H (scale bar=20 mm). Arrows point to persistent
chlamydial inclusions harbouring enlarged reticulate bodies. (C) IFNc
induced persistence decreases t2-NAD(P)H inside the chlamydial
inclusion. Quantitative analysis of t2-NAD(P)H (n=27 ROIs from three
independent experiments; mean 6SEM) at 24 hpi. (D) IFNc induced
persistence decreases the sizes of chlamydial inclusions. Quantitative
analyzes of chlamydial inclusion sizes at 24 hpi (n=27 inclusions from
three independent experiments; mean 6SEM). (E) IFNc induced
persistence increases the ratio of a1/a2 inside the chlamydial inclusions.
Quantitative analysis of ratio of free to protein-bound NAD(P)H (a1/a2)
(n=27 ROIs from three independent experiments; mean 6SEM).
doi:10.1371/journal.ppat.1002108.g005
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channel 2 (emission between 450–500 nm) at 730 nm excitation
by two-photon microscopy corresponds to the peak of NAD(P)H
fluorescence spectrum [18,43]. For the fluorescent detection of
mitochondria, cells were pre-incubated with the mitochondrial
membrane potential sensitive dye, tetramethylrhodamine-ethyl-
ester (TMRE) (10 nM) for 15 minutes. Because of the overlap of
the two-photon excitation cross-section between TMRE and
NAD(P)H, simultaneous excitation of both fluorescence signals
was possible at 730 nm. Fluorescence of channel 2 (NAD(P)H) and
fluorescence of channel 4 (TMRE) were used for creating merged
images by ImageJ.
BacMam transduction, transfection
HEp-2 cells were transduced with CellLight Golgi-GFP
BacMam 2.0 or CellLight Lysosomes-GFP BacMam 2.0 (Invitro-
gen). Transduction was performed simultaneously with C.
trachomatis infection using 10 virus particles per cell. The plasmid
encoding the carboxy terminally GFP-tagged 14-3-3b protein
(RG215940) was purchased from Origene (Bethesda, MD).
Transfection was performed 24 hours before C. trachomatis
infection using 2 ml/ ml Fugene6 transfection reagent (Roche)
and 1 mg / ml DNA according to the manufacturer’s instruction.
GFP Imaging and co-localization analysis
GFP was excited at 840 nm by the two-photon microscope
described above. Cellular autofluorescence was minimal at
840 nm when low excitation power was used. Two-photon
excitation of GFP fluorescence at 730 nm provided minimal
absorption when GFP overexpression was at a low level. To
analyze co-localization, intensity images were exported to the
Keyence BZ9000 Analysis software (Osaka, Japan) and line
intensity profiles of the fluorescence were calculated.
Chlamydial inclusion size measurements
Chlamydial inclusion sizes were analyzed by measuring the area
of inclusions after exporting the grey-scale FLIM intensity images
from SPCImage software to ImageJ (NIH, Bethesda, MD). 54
inclusions were analyzed from three independent experiments.
IFNc induced persistence
To induce persistence, HEp-2 cells were treated with 10 units/
ml IFNc for 24 hours prior to and during C. trachomatis infection.
Chlamydial recovery
To determine the burden of infectious C. trachomatis elementary
bodies after intracellular development, titration experiments were
performed. Infected HEp-2 cells (24 hpi) were mechanically
detached with a cell scraper and re-suspended in fresh growth
medium. Serial dilutions of suspension were inoculated in confluent
cycloheximide-treated HEp-2 cell monolayers with centrifugation-
assisted inoculation. Development of chlamydial inclusions after
30 hours was analyzed on methanol-fixed slides using FITC-labeled
monoclonal chlamydial-LPS antibodies (Dako, Glostrup, Den-
mark). Chlamydial recovery was calculated as IFU/ml by observa-
tion of 10 microscopy fields (406magnification).
Metabolic inhibition of HEp-2 cells
To inhibit host cell glycolysis, glucose starvation or 2FDG
(Sigma) treatment were used. To inhibit host cell oxidative
phosphorylation, antimycin A (Sigma) treatment was used. HEp-2
cells were allowed to adhere for 24 hours. For glucose starvation,
media was changed to media containing no glucose. For 2FDG
and antimycin A treatment, media was changed to media
containing 5 mM 2FDG or 3 nM antimycin A respectively. 15
minutes after the media was changed, cells were infected with C.
trachomatis or were left un-infected. After 24 hours of infections,
FLIM measurements, recovery assays, ATP measurements and
immunofluorescence stainings were performed.
Immunofluorescence staining
Growth media was changed to media containing no glucose or
containing antimycin A (3 nM) prior to infection with C.
trachomatis. After 24 hours of infection, cells were fixed with
Figure 6. Cellular starvation in C. trachomatis-infected cells. HEp-2 cells were left untreated (control) or were treated with 5 mM 2FDG or were
infected with C. trachomatis for 24 hours. (A) Upper panels: Color-coded images of t2-NAD(P)H. Lower panels: Color-coded images of the a1/a2 ratio.
White squares inside the nucleus show representative ROIs used for quantitative analysis (scale bar=20 mm). (B) Treatment of cells with 2FDG or
infection with C. trachomatis increases t2-NAD(P)H inside the nucleus. Quantitative analysis of t2-NAD(P)H (n=54 ROIs from three independent
experiments; mean6SEM). Detailed results of statistical analysis are shown in Table S5A. (C) Treatment of cells with 2FDG or infection with C.
trachomatis decreases the a1/a2 ratio inside the nucleus. Quantitative analysis of a1/a2 ratio (n=54 ROIs from three independent experiments; mean
6SEM). Detailed results of statistical analysis are shown in Table S5B.
doi:10.1371/journal.ppat.1002108.g006
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labelled monoclonal chlamydial-LPS antibodies (Dako). For better
visualization cells were counterstained with 0.1% Evans-blue.
ATP measurements
ATP was measured using a luminometric ATP assay kit (ABD
Bioquest, Sunnyvale, CA) and a microplate reader (Tecan Infinite
200 PRO, Maenedorf, Switzerland). HEp-2 cells were grown in
96-well plates (2000 cells/ well) and treated with the metabolic
inhibitors as described above. ATP assays were performed
according to the manufacturer’s instructions.
Electron microscopy
Cells were fixed with 2% paraformaldehyde and 2.5%
glutaraldehyde in 0.1 M cacodylate buffer for 1 hour. Post-
fixation was performed with 1% OsO4 in O.1 M cacodylate
buffer for 2 hours. Samples were dehydrated with graded ethanol
series and embedded in araldite (Fluka, Buchs, Switzerland).
Ultrathin sections were stained with uranyl acetate and lead citrate
and were examined with a Philips EM 400 transmission electron
microscope.
Statistical hypothesis testing
For all comparisons, we used nonparametric models for
longitudinal data as described previously [44]. Due to small
sample sizes, ANOVA-type statistics were applied with a Box-
approximation. Adjustment for multiple testing: Overall, six sets of
statistical tests were carried out (Figures 1B, 3B, 4D, 6B, 6C, S4B).
The overall significance level was set to 0.05. Within each set,
adjustment for multiple testing was performed using the
hierarchical procedure by Bonferroni-Holm (Bonf-Holm). To
account for the testing of six sets of hypotheses, a Bonferroni
correction was performed overall.
Accession numbers of proteins (Swiss-Prot):
1433B_HUMAN (YWHAB): P31946.
Supporting Information
Figure S1 Spectral characterization of autofluorescence
signals at 730 nm excitation. (A) Spectral characterization of
autofluorescence signals of non-infected HEp-2 cells (upper panels)
and of C. trachomatis-infected cells at 24 hpi (lower panels) shows
typical NAD(P)H fluorescence (scale bar=20 mm). (B) Quantifi-
cation of fluorescence intensity of selected ROIs (white squares) in
host cell mitochondria, cytosol, nucleus and chlamydial inclusion
at 24 hpi (n=3; mean 6SEM). Fluorescence intensity values were
normalized to the fluorescence intensity of the media in each
emission channels. There is no shift in the peak emission
wavelengths of autofluorescence originating from the chlamydial
inclusion compared to host cell mitochondria. The peak of
emission between 450–500 nm at 730 nm excitation by two-
photon microscopy corresponds to the peak of the NAD(P)H
fluorescence spectrum.
(TIF)
Figure S2 Autofluorescence intensity and frequency
distribution of t2-NAD(P)H. (A) Autofluorescence intensities
were used to define different cellular compartments (upper panels)
and ROIs were transferred to color-coded images of t2-NAD(P)H
(lower panels) of a non-infected and a C. trachomatis-infected cell at
24 hpi (scale bar= 10 mm; M=mitochondria, I=inclusion,
N=nucleus). The line in the C. trachomatis-infected cell (upper
right) marks the area that was used for analysis of fluorescence
intensity in Figure S2B. (B) Analysis of the fluorescence intensity of
the line shown in Figure S2A in C. trachomatis-infected cell. The
fluorescence intensity is different in host cell mitochondria, nucleus
and inside the chlamydial inclusion indicating the different
concentration of NAD(P)H in these cellular compartments. The
different intensity signal enables the separation of these cellular
compartments (M=mitochondria, I=inclusion, N=nucleus). (C)
Histogram of t2-NAD(P)H in the cytosolic, mitochondrial and
nuclear compartments of non-infected cells and in the chlamydial
inclusion of infected cells at 24 hpi (n=54 from three independent
experiments).
(TIF)
Figure S3 Co-localization analysis of NAD(P)H fluores-
cence with the mitochondria marker, TMRE. (A) Intensity
profile (middle panel) of the line indicated in the overlay picture
(upper panel) and in the magnified picture (lower panel) show
complete co-localization of TMRE and NAD(P)H fluorescence in
non-infected HEp-2 cells. (B) Intensity profile (middle panel) of the
line indicated in the overlay picture (upper panel) and in the
magnified picture (lower panel) show co-localization of TMRE
and NAD(P)H fluorescence in the mitochondria but not in the
chlamydial inclusion and on the inclusion membrane in C.
trachomatis-infected HEp-2 cell at 24 hpi.
(TIF)
Figure S4 FLIM analysis of C. trachomatis metabolism.
(A) The scatter plot shows the homogenous distribution of the
average t2-NAD(P)H values in C. trachomatis inclusions at 24 hpi
and the heterogeneous distribution at 48 hpi (n=54 from three
independent experiments). (B) Quantitative analysis of the ratio of
free to protein-bound NAD(P)H (a1/a2) inside the C. trachomatis
inclusion of NAD(P)H FLIM images after the indicated time
points of infection (n=54; mean6SEM). Detailed results of
statistical analysis are shown in Table S3B.
(TIF)
Figure S5 NAD(P)H autofluorescence intensity in the
chlamydial inclusion 18 hpi, 24 hpi and 48 hpi. (A)
Pseudo-colour images of NAD(P)H fluorescence intensity mea-
sured by FLIM in C. trachomatis-infected cells 18 hpi, 24 hpi and
48 hpi (scale bars=20 mm). (B) Histogram of NAD(P)H autofluo-
rescence distribution inside the chlamydial inclusion after 18 hours
(n=442 pixels), 24 hours (n=1060 pixels) and 48 hours (n=1561
pixels) of infection. (C) Enlarged images of representative cells used
for NAD(P)H fluorescence intensity analysis (scale bars=10 mm;
I=inclusion, N=nucleus).
(TIF)
Figure S6 Changes of t2-NAD(P)H inside C. pneumoniae
inclusions during the intracellular developmental cycle.
(A) Changes of t2-NAD(P)H inside the C. pneumoniae inclusion
during the bacterial developmental cycle. HEp-2 cells were
infected with C. pneumoniae for 36, 48, 60, 72, 84 and 96 hours.
(B) Quantitative analysis of t2-NAD(P)H inside the C. pneumoniae
inclusion and of C. pneumoniae inclusion sizes (n=36 (36 hpi);
n=32 (48 hpi); n=42 (60 hpi); n=27 (84 hpi); n=18 (96 hpi)
from four independent experiments; mean6SEM).
(TIF)
Figure S7 Impact of host-cell metabolism inhibition on
ATP levels and t2-NAD(P)H. (A) Cellular ATP levels under
glucose starvation and inhibition of oxidative phosphorylation by
antimycin A. (B) Histogram of t2-NAD(P)H in the C.trachomatis-
inclusions under different metabolic perturbations.
(TIF)
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Fluorescence lifetimes, relative amounts and fluorescence quantum
yields of free and protein-bound NAD(P)H in the cytosol,
mitochondria and nucleus of non-infected HEp-2 cells and in
the C. trachomatis inclusion. t1: fluorescence lifetime of free
NAD(P)H, t2: fluorescence lifetime of protein-bound NAD(P)H,
a1: relative amount of free NAD(P)H, a2: relative amount of
protein-bound NAD(P)H, q1: fluorescence quantum yield of free
NAD(P)H, q2: fluorescence quantum yield of protein-bound
NAD(P)H (n=54; mean 6 SD).
(DOC)
Table S2 Statistical analysis of t2-NAD(P)H in cytosol,
mitochondria, nucleus of non-infected HEp-2 and in
chlamydial inclusion at 24 hpi. The model included
experimental days (three per group, hence six in total) and
compartment (cytosol, mitochondria, nucleus, inclusion) as
independent factors and images per day (six) as well as cells per
image (three) as repeated measures with all main effected and
interactions. The dependent variable was t2-NAD(P)H in nucleus.
Compartment was tested overall as well as comparing inclusion
with every other compartment.
(DOC)
Table S3 Statistical analysis of t2-NAD(P)H and a1/a2 in
the chlamydial inclusion 12 hpi, 24 hpi and 48 hpi. The
model included experimental days (three per group, hence six in
total) and time point (comparison 1: 12hpi vs 24hpi, comparison 2:
24hpi vs 48hpi) as independent factors and images per day (six) as
well as cells per image (three) as repeated measures with all main
effected and interactions. The dependent variable were t2-
NAD(P)H (A) and a1/a2 (B). Differences in time points were tested.
(DOC)
Table S4 Statistical analysis of t2-NAD(P)H in the
chlamydial inclusion under different metabolic inhibi-
tion conditions at 24 hpi. The model included experimental
days (three per group, hence six in total) and treatment
(comparison 1: control vs no glucose, comparison 2: control vs
antimycin A) as independent factors and images per day (six) as
well as cells per image (three) as repeated measures with all main
effected and interactions. The dependent variable was t2-
NAD(P)H.
(DOC)
Table S5 Statistical analysis of t2-NAD(P)H and a1/a2 in
the host cell nucleus. The models included experimental days
(three per group, hence six in total) and treatment (comparison 1:
2FDG vs controls, comparison 2: C. trachomatis at 24 hpi vs
controls) as independent factors and images per day (six) as well as
cells per image (three) as repeated measures with all main effected
and interactions. The dependent variables were t2-NAD(P)H (A)
and a1/a2 (B).
(DOC)
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